Garadacimab-gxii bulk supplier for pharma manufacturers

Garadacimab-Gxii 200mg/1.2ml Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 200mg/1.2ml

Reference Brands: Andembry (USA/EU)

Garadacimab-gxii, marketed as Andembry, is a monoclonal antibody used for the prevention of hereditary angioedema (HAE) attacks in adolescents and adults. It works by inhibiting activated coagulation factor XIIa (FXIIa), which reduces the production of bradykinin, a substance that causes swelling in HAE attacks. Administered once monthly as a subcutaneous injection, it helps patients manage and prevent recurrent episodes of HAE, improving quality of life.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Garadacimab-Gxii — third party manufacturing & bulk supply

Garadacimab-Gxii 200mg/1.2ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Garadacimab-Gxii is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Garadacimab-Gxii listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Garadacimab-Gxii →

Back to Listing

Frequently Asked Questions

Garadacimab-gxii is listed as Injection in 200mg/1.2ml. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Garadacimab-gxii is referenced against Andembry (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.